done in the treatment of dopamineinduced psychosis in Parkinson’s disease:an open pilot trial[J].Mov Disord,2000,15(6):1230
[6] Meco G,Alessandri A,Giustini P,et al.Risperidone in levodopainduced psychosis in advanced Parkinson’s disease:an openlabel,longterm study[J].Mov Disord,1997,12(4):610
[7] Factor SA,Molho ES,Friedman JH. Risperidone and Parkinson’s disease [J]. Mov Disord,2001,12:364
[8] Ellis T,Cudkowicz ME,Sexton PM,et al.Clozapine and risperidone treatment of psychosis in Parkinson’s disease[J].J Neuropsychiatry Clin Neurosci,2000,12(3):364
[9] Wolters EC,Jansen EN,TuynmanQua HG,et al.Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson’s disease[J].Neurology,1996,47(4):1085
[10] Fernandez HH,Trieschmann ME,Friedman JH.The treatment of psychosis in Parkinson’s disease:safety considerations[J].Drug Saf,2003,26:643
[11] Goetz CG,Blasucci LM,Leurgans S,et al.Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients[J].Neurology,2000,55(6):789
[12] Breier A,Sutton VK,Feldman PD,et al.Olanzapine in the treatment of dopamimeticinduced psychosis in patients with Parkinson’s disease[J].Biol Psychiatry,2002,52(5):438
[13] Ondo WG,Levy JK,Vuong KD,et al.Olanzapine treatment for dopaminergicinduced hallucinations[J].Mov Disord,2002,17(5):1031
[14] Reddy S,Factor SA,Molho ES,et al.The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia[J].Mov Disord,2002,17(4):678
[15] Morgante L,Epifanio A,Spina E,et al.Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis[J].lin Neuropharmacol 2004,27(4):153
[16] Klein C,Prokhorov T,Miniovich A,et al.Longterm followup (24 months) of quetiapine treatment in druginduced Parkinson disease psychosis[J].Clin Neuropharmacol,2006,29(4):215
[17] Juri C,Chana P,Tapia J,et al.Quetiapine
上一页 [1] [2] [3] [4] 下一页